21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Compositions and methods for preparing polymeric films loaded with uniformly distributed drug particles
#1202Compositions and methods for the delivery of nucleic acids
#1203Pharmaceutical formulations
#1204USE OF LOW DOSE GLUCAGON
#1205WATER SOLUBLE FORMULATION (LIQUID) OF CURCUMINOIDS AND PROCESS THEREOF
#1206Topical composition
#1207Medroxyprogesterone acetate injectable compositions and methods of use
#1208Veterinary composition comprising imidacloprid, moxidectin and praziquantel for cutaneous topical application (spot on), for the treatment and prevention of ecto and endoparasitoses affecting dogs
#1209TRANSDERMAL PREPARATION
#1210Pharmaceutical formulation containing gelling agent
#1211Liposome containing compositions and their use in personal care and food products
#1212NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE
#1213Excipient compounds for protein processing
#1214Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#1215METHODS FOR TREATMENT OF CERVICAL INSUFFICIENCY
#1216Solid Compositions Comprising a Glucokinase Activator and Methods of Making and Using the Same
#1217Apremilast pharmaceutical compositions
#1218COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
#1219PERCUTANEOUSLY ABSORBABLE COMPOSITION CONTROLLED IN RELEASE OF WATER-SOLUBLE EFFECTIVE INGREDIENT
#1220High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#1221Formulation comprising a gemcitabine-prodrug
#1222HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#1223FORMULATION FOR TREATMENT OF PERIPHERAL JOINTS, SPINAL JOINTS AND/OR EXTRACELLULAR MATRIX ELEMENTS OF CONNECTIVE TISSUE, METHOD OF MANUFACTURE AND USES
#1224CNP prodrugs with large carrier moieties
#1225Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#1226Pharmaceutical Formulation Containing Gelling Agent
#1227Compositions and kits useful for treatment of respiratory illness
#1228Skin disinfectant composition
#1229NASAL DOSAGE FORMS OF DIHYDROERGOTAMINE
#1230Method for the cryopreservation of cells for therapeutic purposes
#1231FORMULATIONS OF BENDAMUSTINE
#1232Stabilised Compositions of Factor VII Polypeptides
#1233Drug formulations
#1234FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
#1235Precipitation resistant small molecule drug formulations
#1236Methods for treating cancer
#1237PRODUCT AND METHOD FOR TREATMENT OF BIOFILM, INCLUDING CONTROL OF SUBSTRATE COLONIZATION AND TREATMENT OF INFECTION
#1238BIPHASIX CANNABINOID DELIVERY
#1239Film dosage form with extended release mucoadhesive particles
#1240Long-acting polymeric delivery systems
#1241COMPOSITIONS AND METHODS OF TREATING AND/OR PREVENTING CANCER
#1242Pharmaceutical composition for injection
#1243METHODS OF TREATMENT OF ANORECTAL AND GENITAL DISORDERS
#1244Topical nifedipine formulations and uses thereof
#1245ARYLSULFANYL COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS
#1246Sustained-release preparation of poorly soluble drug
#1247Dermal Delivery Compositions And Methods
#1248Antimicrobial compositions for
#1249ALDITOL-FREE, STORAGE-STABLE THYROID HORMONE ACTIVE DRUG FORMULATIONS AND METHODS FOR THEIR PRODUCTION
#1250Formulation of nanostructured gels for increased agent loading and adhesion
#1251Pharmaceutical composition, use of mefloquine in fixed dose, and method for treating tuberculosis
#1252PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
#1253Benzenesulfonamide derivatives and method for treating cancer
#1254Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids
#1255Veterinary compositions for use in treating mastitis, and associated methods
#1256Pharmaceutical compositions of IL-2
#1257TREATMENT COMPOSITIONS PROVIDING AN ANTIMICROBIAL BENEFIT
#1258FORMULATIONS OF BENDAMUSTINE
#1259FORMULATIONS OF BENDAMUSTINE
#1260Compounded solutions of diclofenac and lidocaine and methods
#1261NOVEL FORMULATION OF DICLOFENAC
#1262Subcutaneous HER2 antibody formulations
#126317-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS
#1264Fulvestrant formulations
#1265Slow-release conjugates of SN-38
#1266Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
#1267Patch
#1268Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica
#1269Epinephrine spray formulations
#1270SYSTEMS AND METHODS FOR TREATING NAIL FUNGUS
#1271Pharmaceutical formulations for the oral delivery of peptide drugs
#1272Methods for pharmacologic treatment of stroke
#1273Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
#1274TOPICAL NON-AQUEOUS PHARMACEUTICAL FORMULATIONS CONTAINING AN ALKYL SULFOXIDE FOR THE TREATMENT OF TOPICAL REFERENCE INFECTIONS
#1275Compositions for biological systems and methods for preparing and using the same
#1276Composition, device and method for delayed and sustained release of brain energy molecules
#1277METHOD OF TRANSPORTING AN AGENT ACROSS BLOOD-BRAIN, BLOOD-COCHLEAR OR BLOOD-CEREBROSPINAL FLUID BARRIER
#1278PROTEIN COMPOSITIONS AND USE THEREOF
#1279Compositions and methods for treating nail infections
#1280TOPICAL FORMULATIONS
#1281Antiviral pharmaceutical composition for topical use
#1282TOPICAL CORTICOSTEROID COMPOSITIONS
#1283Analgesic compositions
#1284USE OF COMPOUNDS INCLUDING A SULFOXIDE OR SULFONE FUNCTION AND AN AMIDE FUNCTION AS SOLVENTS AND NEW SOLVENTS
#1285Rapid action insulin formulations and pharmaceutical delivery systems
#1286Solid preparation including colorant
#1287Stabilized glucagon solutions
#1288Sialylation-increasing therapies for diseases associated with oxidative stress
#1289IMPLANTABLE DEVICES FOR TREATING HIV
#1290METHODS AND COMPOSITIONS FOR SOFT ANTICHOLINERGIC ZWITTERIONS
#1291BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT
#1292Compositions with permeation enhancers for drug delivery
#1293PH-sensitive linkers for delivering a therapeutic agent
#1294Sterile formulation comprising a stable phosphorothioate oligonucleotide
#1295COSMETIC AND PHARMACEUTICAL FOAM
#1296Method of synthesis of an ionizable cationic lipid
#1297DISPERSION COMPRISING AN ESTERIFIED CELLULOSE ETHER
#1298NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE
#1299Stable liquid formulations of melphalan
#1300Nanoparticles functionalized with sulfur-containing polymers
#1301FORMULATIONS OF BENDAMUSTINE
#1302Reaction platform and method for making pollen based materials and uses thereof
#1303Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions
#1304Multicomponent Degradable Cationic Polymers
#1305Anti-CD3 antibody formulations
#1306Pharmacokinetically extended action topical hair growth formulation, and administration method
#1307Liquid Protein Formulations Containing Thiamine
#1308Liquid protein formulations containing cimetidine
#1309Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease
#1310Ionizable cationic lipid for RNA delivery
#1311Ionizable cationic lipid for RNA delivery
#1312Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
#1313Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
#1314Aqueous Ophthalmic Composition
#1315Pharmaceutical formulation containing tadalafil
#1316Liquid protein formulations containing thiamine pyrophosphate (TPP)
#1317Oral solid formulation containing irinotecan and method of preparing the same
#1318Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
#1319Sublingual formulation of riluzole
#1320Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#1321Foamable formulation
#1322Methods of making and using polyphenols complexed with a protein, peptide, amino acid, polysaccaride, disaccharide, or monosaccharide
#1323COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#1324SELF-FOAMING COMPOSITIONS AND METHODS
#1325IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#1326Compounded solutions of diclofenac and lidocaine and methods
#1327Lipids and compositions for the delivery of therapeutics
#1328LIQUID FORMULATIONS OF BENDAMUSTINE
#1329Stabilized pharmaceutical composition and method for preparing same
#1330Transdermal compositions of ibuprofen and methods of use thereof
#1331Treatment of pain with topical diclofenac
#1332ExPEC glycoconjugate vaccine formulations
#1333Compositions comprising anakinra
#1334STABLE LIQUID PHARMACEUTICAL COMPOSITIONS OF BORTEZOMIB
#1335Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
#1336STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY
#1337METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING BCN057 OR BCN512
#1338Lipids and compositions for the delivery of therapeutics
#1339Injectable formulation
#1340Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof
#1341Pharmacokinetically extended action topical hair growth formulation, and administration method
#1342Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)
#1343Stabilised Solid Compositions of Factor VII Polypeptides
#1344Topical localized isoxazoline formulation
#1345Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
#1346Pharmaceutical composition comprising polypeptide
#1347NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#1348Sincalide Formulations
#1349COMPOSITION AND FORMULATION BASED ON PTERODON PUBESCENS BENTH. AND CORDIA VERBENACEA DC EXTRACTS/ESSENTIAL OILS, AND USES THEREOF
#1350Melatonin for Preventing and Treating Radiation Cystitis
#1351Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
#1352Pharmaceutical formulation containing gelling agent
#1353Depot formulations of a local anesthetic and methods for preparation thereof
#1354Lipids and compositions for the delivery of therapeutics
#1355ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION
#1356Sustained-release pharmaceutical composition
#1357Biocompatible hydrogel treatments for retinal detachment
#1358Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
#1359Stable Formulation of Insulin Glulisine
#1360RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules
#1361Suspension containing nano-cocrystal and manufacturing method
#1362Hydrocortisone acetate suppository formulation for treatment of disease
#1363Method of producing transdermal absorption sheet
#1364Ophthalmic compositions and methods of use
#1365Pharmaceutical formulation containing gelling agent
#1366INJECTABLE BUPRENORPHINE FORMULATION
#1367Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
#1368Iodophor composition and methods of use
#1369Compositions and methods for preventing or treating pulmonary hypertension
#1370TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF
#1371Long-acting polymeric delivery systems
#1372Formulations of bendamustine
#1373AMNIOTIC FLUID-DERIVED PREPARATIONS
#1374Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#1375Stable 5-methyltetrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms
#1376Formulations of bendamustine
#1377Method of manufacturing an osmotic delivery device
#1378Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
#1379Malodor neutralizing composition
#1380Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
#1381Polymeric hGH prodrugs
#1382Compositions for biological systems and methods for preparing and using the same
#1383Compositions for biological systems and methods for preparing and using the same
#1384COMPOSITIONS FOR THE DELIVERY OF TRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH
#1385Formulation inhibiting effects of low acid environment
#1386Therapeutic uses of berberine formulations
#1387SULFONAMIDE PHARMACEUTICAL COMPOSITION
#1388SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#1389ANTI CANCEROUS, ANTIPARASITE (TOXOPLASMA GONDII (PROTOZON) AND ANTIMICROBIAL EFFECT AND DOSAGE OF GINGER (ZINGIBER OFFICINALE) EXTRACT
#1390THE ANTI CANCEROUS, ANTIPARASITE (TOXOPLASMA GONDII (PROTOZOON) AND ANTIMICROBIAL EFFECT AND DOSAGE OF NIGELLA (NIGELLA SATIVA) EXTRACT
#1391Salicylate compound composition
#1392Chemically stable compositions of a pharmaceutical active agent in a multi- chambered delivery system for mucosal delivery
#1393Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use
#1394ANTIFUNGAL COMPOSITIONS FOR THETREATMENTOF SKIN AND NAILS
#1395Methods for producing stable therapeutic formulations in aprotic polar solvents
#1396Topical use of an antimicrobial formulation
#1397Long-acting polymeric delivery systems
#1398PARENTERAL COMPOSITIONS AND USES THEREOF
#1399ORAL IODINE DOSAGE FORM
#1400NOVEL PHARMACEUTICAL FORMULATION
#1401Pharmaceutical combination composition comprising complex formulations of Ivacaftor and Lumacaftor and their salts and derivatives, process for their preparation thereof and pharmaceutical compositions containing them
#1402PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE OR PROTEIN DRUGS
#1403METHODS OF INCREASING SOLUBILITY OF POORLY SOLUBLE COMPOUNDS AND METHODS OF MAKING AND USING FORMULATIONS OF SUCH COMPOUND
#1404Chewable gelled emulsions
#1405Topical formulation
#1406Soft chewable pharmaceutical products
#1407Long-acting polymeric delivery systems
#1408Sincalide Formulations
#1409Antimicrobial peptide stimulating cleansing composition
#1410Preparation containing cephalosporin having a catechol moiety
#1411Body Cavity Foams
#1412Ionizable cationic lipid for RNA delivery
#1413DICLOFENAC TOPICAL FORMULATION
#1414Compositions and methods for reducing overdose
#1415Injection preparation and method for producing same
#1416Pharmaceutical Compositions Comprising Canagliflozin
#1417USE OF MESO- AND NANOPOROUS MATERIAL FOR SURFACTANT TRAPPING IN NANOPARTICLE SUSPENSIONS
#1418Factor VIII formulation
#1419Mucus penetrating gene carriers
#1420Lyophilised pharmaceutical formulation and its use
#1421Topical healing and scar treatment composition
#1422FORMULATIONS OF CYCLOPHOSPHAMIDE LIQUID CONCENTRATE
#1423Kinase inhibitors
#1424HYDROALCOHOLIC SYSTEM FOR NAIL TREATMENT
#1425Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
#1426STABILIZATION OF FSH
#1427Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
#1428TOPICAL FORMULATIONS
#1429Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
#1430Nanoparticle compositions and methods for treating onychomychosis
#1431Silicone-based biophotonic compositions and uses thereof
#1432METHODS AND TOPICAL FORMULATIONS FOR TREATING INFLAMMATION
#1433Aqueous formulation comprising paracetamol and ibuprofen
#1434HERBAL OINTMENT FOR MUSCULOSKELETAL AND JOINT-RELATED CONDITIONS
#1435Ocular eyelid scrub composition for the treatment of demodex blepharitis
#1436SILICONE OIL-CONTAINING FORMULATIONS FOR NASAL APPLICATION
#1437Pharmaceutical composition comprising 7β-hydroxycholesterol intravenous administration
#1438Long acting injectable formulations
#1439Antibacterial water
#1440PHOSPHOLIPID DEPOT
#1441Compositions of a polyorthoester and an aprotic solvent
#1442IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#1443SOFT CHEWABLE PHARMACEUTICAL PRODUCTS
#1444Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
#1445SOFT CHEWABLE PHARMACEUTICAL PRODUCTS
#1446Antimicrobial compositions and methods for their use
#1447Viscosity-reducing excipient compounds for protein formulations
#1448Compositions and methods for reducing overdose
#1449Preparation method for antithyroid ointment for external application
#1450CONCENTRATED FELBAMATE FORMULATIONS FOR PARENTERAL ADMINISTRATION
#1451DOPA decarboxylase inhibitor compositions
#1452METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#1453CHEMICALLY STABLE COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM FOR OROMUCOSAL DELIVERY
#1454TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS
#1455COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#1456Botanical formulations
#1457Composition containing apomorphine and a divalent metal cation
#1458LIQUID PHARMACEUTICAL FORMULATIONS OF PEMETREXED
#1459NON-AQUEOUS GLUCAGON FORMULATIONS
#1460Subcutaneous formulations of anti-CD38 antibodies and their uses
#1461Lipocationic dendrimers and uses thereof
#1462HOMEOPATHIC TOPICAL GEL FOR TRANSDERMAL DELIVERY OF COLCHICINE FORMULATIONS AND METHOD OF USE
#1463Ionizable cationic lipid for RNA delivery
#1464VOLATILE ANESTHETIC COMPOSITIONS AND METHODS OF USE
#1465Pharmaceutical formulation containing gelling agent
#1466Nanoemulsions having reversible continuous and dispersed phases
#1467PHARMACEUTICAL COMPOSITION
#1468PHARMACEUTICAL COMPOSITION
#1469Foamable otic pharmaceutical compositions
#1470SOFT CHEWABLE PHARMACEUTICAL PRODUCTS
#1471Compositions and Methods for Treatment of Inflammatory Skin Conditions Using Allantoin
#1472Ionizable cationic lipid for RNA delivery
#1473Compositions of a polyorthoester and an aprotic solvent
#1474Compositions and kits useful for treatment of respiratory illness
#1475Pharmaceutical composition for treating inflammation and pain
#1476Pharmaceutical composition and administrations thereof
#1477Frozen therapeutic dose and package
#1478Formulation comprising a gemcitabine-prodrug
#1479Transdermal formulations of pergolide and uses thereof
#1480Factor VIII formulations
#1481Methods for producing stable therapeutic formulations in aprotic polar solvents
#1482METHOD FOR TREATMENT OF OSTEOARTHRITIS AND OTHER JOINT RELATED INJURIES AND CONDITIONS
#1483Antiviral drug
#1484Osmotic delivery device comprising an insulinotropic peptide and uses thereof
#1485COMPOSITION AND METHOD FOR TREATING OTITIS
#1486Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#1487Topical Localized Isoxazoline Formulation
#1488Functionalization of nanoparticles with polythioaminal thiol-containing polymers
#1489Stable formulations for parenteral injection of peptide drugs
#1490ANIMAL TISSUE COLONIZATION AND TREATMENT OF INFECTION
#1491Long-acting polymeric delivery systems
#1492Method of manufacture of GnRH-containing gel
#1493Composition comprising bortezomib
#1494Long-acting polymeric delivery systems
#1495Aprepitant oral liquid formulations
#1496Preparation containing tetracyclic compound at high dose
#1497Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#1498Stable protein formulations comprising a molar excess of sorbitol
#1499NOVEL FORMULATIONS OF VOLATILE ANESTHETICS AND METHODS OF USE FOR REDUCING INFLAMMATION
#1500Stable veterinary anthelmintic formulations